Asthma  is one of the most common long-term health conditions, so why does access to diagnosis and treatment still depend on where you live, who you see, or even your ethnicity? To mark World Asthma Day, we spoke with Carol Stonham MBE, a leading respiratory nurse, about what true accessibility... read more →

NObreath® FeNO device and Gastrolyzer® range of devices are now available across the Middle East. Bedfont® Scientific Limited, a world leader in breath analysis with over 47 years of knowledge and expertise in designing and manufacturing medical breath analysis devices, has partnered with Tebaba Medical Services, a leading supplier of... read more →

On Wednesday, 27th November, the National Institute for Health and Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN) updated and published a joint guideline on asthma diagnosis, monitoring, and chronic asthma management. Streamlining asthma management BTS/SIGN and NICE published guidelines independent of each... read more →

Bedfont® outlines key updates and offers support for healthcare professionals navigating the changes. Bedfont® Scientific Ltd., world leaders in breath analysis with over 47 years of knowledge in designing and manufacturing medical breath analysis devices, welcomes the recent update to the National Institute for Health and Care Excellence (NICE) guidelines... read more →

Bedfont® Scientific Limited hosted an informative webinar Children with Asthma, with seasoned respiratory nurse Carol Stonham MBE leading the discussion along with Kirsty at Medway Asthma Self-Help (MASH). The webinar was a private screening for local Medway football coaches and gave valuable insights on managing, treating and recognising an asthma... read more →

World Lung Day was created in 2017 by the Forum of International Respiratory Societies (FIRS), the day was established to raise awareness about lung health and advocate for better lung health globally. Celebrated annually on the 25th of September, FIRS brings together several major respiratory organisations, including the American Thoracic... read more →

Methods of measuring FeNO Fractional exhaled nitric oxide (FeNO) measurement plays a crucial role in the diagnosis and management of airway inflammation. FeNO testing is recommended by the National Institute for Health and Care Excellence (NICE) to help diagnose asthma1, with the NObreath® device one of three devices recommended by... read more →

FeNO Testing in As Although airway eosinophilic inflathma Caremmation is a key characteristic of asthma, there are few methods available to measure it. This inflammation can be assessed by measuring eosinophils and eosinophilic cationic protein (ECP) in sputum or by measuring ECP in blood samples1. However, these methods are considered... read more →

Like any healthcare investment, consideration needs to be given when deciding which fractional exhaled nitric oxide (FeNO) device might best suit the clinical area in which it will be used. So, what would be sensible to consider when including FeNO devices for implementation into the respiratory pathway? And how does... read more →

To mark Love Your Lungs Week, Bedfont® Scientific Ltd. raises awareness of FeNO testing in asthma care. Love Your Lungs Week is an annual event which takes place from 21st to 27th June. The event aims to raise lung health awareness and promote habits that support respiratory well-being. Bedfont®, world... read more →